Skip to main content

Ferric Carboxymaltose Dosage

Medically reviewed by Last updated on Sep 27, 2021.

Applies to the following strengths: (as elemental iron) 50 mg/mL

Usual Adult Dose for Iron Deficiency Anemia

Patients weighing 50 kg or more: Two doses of 750 mg via slow IV push or infusion separated by at least 7 days
Patients weighing less than 50 kg: Two doses of 15 mg/kg via slow IV push or infusion separated by at least 7 days
Maximum dose: Total cumulative dose should not exceed 1500 mg of iron per course

-The dosage is expressed in mg of elemental iron.
-Treatment may be repeated if iron deficiency anemia recurs

Use: Treatment of iron deficiency anemia in adults with an intolerance or unsatisfactory response to oral iron and in adults with non-dialysis dependent chronic kidney disease

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available


-Hypersensitivity to any of the ingredients

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:
-Administer either as an undiluted slow IV push or by infusion over at least 15 minutes
-When administering as a slow IV push give at a rate of 100 mg per minute.

Storage requirements: Solutions diluted in 0.9% sodium chloride to a concentration of 2 to 4 mg/mL of elemental iron are stable for 72 hours when stored at room temperature.

IV compatibility: The manufacturer product information should be consulted; a solution IV infusion should only be made using 0.9% sodium chloride

General monitoring:
-Hypersensitivity: Signs and symptoms of hypersensitivity reactions during and following ferric carboxymaltose administration.

-Each mL of ferric carboxymaltose injection contains 50 mg of elemental iron

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.